Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery.
Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery. Ann Thorac Surg. 2020 01; 109(1):164-170.
View in:
PubMed
subject areas
Biomarkers
Blood Proteins
Cardiac Surgical Procedures
Child
Child, Preschool
Female
Galectin 3
Galectins
Glial Fibrillary Acidic Protein
Heart Defects, Congenital
Humans
Infant
Infant, Newborn
Interleukin-1 Receptor-Like 1 Protein
Male
Natriuretic Peptide, Brain
Patient Readmission
Predictive Value of Tests
Prospective Studies
Time Factors
authors with profiles
Luca Vricella